title: Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor.
authors: Division of Hematology, Hospital Universitario 12 de Octubre, Departamento de Medicina, Universidad Complutense, Avd de Cordoba s/n., 28041, Madrid, Spain, jmarti01@ucm.es.
authors: Joaquín
authors: J
authors: Martinez-Lopez
authors: Ana
authors: A
authors: Jimenez
authors: Jorge
authors: J
authors: Sanchez-Calero
authors: Dolores
authors: D
authors: Monteagudo
authors: María
authors: M
authors: Urbanowicz
authors: Irene
authors: I
authors: Cañamares-Orbis
authors: Susana
authors: S
authors: Cortijo-Cascajares
authors: Rosa
authors: R
authors: Ayala
mesh_terms: D019046:Bone Marrow Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D009570:Nitriles; D011087:Polycythemia Vera / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D016896:Treatment Outcome; D055815:Young Adult; D017086:beta-Thalassemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D055538:delta-Thalassemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases